Planet 13 Holdings (PLNH) Capital Expenditures Growth (3y) (2024 - 2026)
Planet 13 Holdings (PLNH) Capital Expenditures Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn | 6.52% |
| 3 | Zoetis | 32.68 Bn | 30.74 Bn | 1.62 Bn | 232.22% |
| 4 | Takeda Pharmaceutical | 27.59 Bn | 23.53 Bn | 4.39 Bn | 1.64% |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | 75.58% |
| 6 | RedHill Biopharma | 20.54 Bn | 20.54 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | -5.84% |
| 8 | Neurocrine Biosciences | 17.83 Bn | 16.51 Bn | 800.70 Mn | 32.64% |
| 9 | Elanco Animal Health | 12.60 Bn | 12.17 Bn | 785.00 Mn | 28.56% |
| 10 | Planet 13 Holdings | 37.38 Mn | 21.13 Mn | 9.41 Mn | -43.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.32% |
| Dec 31, 2025 | -28.09% |
| Sep 30, 2025 | -33.64% |
| Jun 30, 2025 | -33.42% |
| Mar 31, 2025 | -12.57% |
| Dec 31, 2024 | -39.10% |
| Sep 30, 2024 | -7.12% |
| Jun 30, 2024 | -20.21% |
| Mar 31, 2024 | -5.32% |